{"prompt": "['056-F275, Clinical Investigation Plan Template, Version 2.0', 'Page 75 of 115', 'The AFEQT questionnaire will be utilized for this objective. The questionnaire is an atrial fibrillation specific', \"health-related quality of life questionnaire to assess the impact of AF on a subject's life. The overall score\", 'ranges from 0 - 100, with 0 corresponds to complete disability and 100 corresponds to no disability.', 'Analysis Methods', 'Change in AFEQT score is defined as 12-month AFEQT score minus baseline AFEQT score. Change', 'in', 'AFEQT scores will be assessed utilizing a one-sample: t-test. A two-sided 95% confidence interval will be', 'calculated based on the t-distribution.', 'Additionally, summary statistics (e.g. mean, SD, median, range) and graphical methods will be used to', 'summarize the change in AFEQT scores from baseline through 12 months.', 'Performance criteria', 'If the p-value from the one-sample t-test after adjusting for the Hommel procedure is < 0.025, the objective', 'will be considered met.', 'Determination of Subjects/Data for Analysis', 'All enrolled subjects who have the Arctic Front Advance Cardiac CryoAblation Catheter inserted into', 'vasculature and have completed baseline and 12 month questionnaires will be included.', 'Additional Analyses', 'The AFEQT questionnaire has three subscale scores, Daily Activities Subscale, Treatment Concern, and', 'Treatment satisfaction. Each subscale ranges from o - 100, where 0 corresponds to low quality-of-life and', '100 corresponds to high quality of life.', 'Change in AFEQT subscale score is defined as 12-month AFEQT subscale score minus baseline AFEQT', 'subscale score. A two-sided 95% confidence interval will be calculated based on the t-distribution.', 'Version 4, 10NOV2016', 'Confidential']['056-F275, Clinical Investigation Plan Template, Version 2.0', 'Page 76 of 115', '18.3.3.2 Medical Outcome Study Short Form-12 (SF-12)', 'The following hypotheses will be tested. Each will be tested in a one-sided test at the 0.025 significance', 'level:', 'Ho: ASF-12mentai=0 -', 'Ho: ASF-12physica== -', 'Ha: ASF- - 0', 'Ha: ASF-12physicar>0', 'Where ASF-12mental - is the change in ASF-12 - mental score from baseline to 12 months, and ASF - 12 -physical is the', 'change in ASF-12 physical score from baseline to 12 months', 'Endpoint Definition', 'The Medical Outcome Study Short Form-12 (SF-12) questionnaire will be utilized for this objective. The SF-', \"12 questionnaire is a health-related quality of life questionnaire to evaluate the subject's mental and physical\", 'performance. Physical and mental health component scores are calculated using responses to 12 questions', 'with a response range from o - 100, with o corresponds to lowest level of health and 100 indicates highest', 'level of health.', 'Analysis Methods', 'Change in SF-12 component score is defined as 12-month SF-12 score minus baseline SF-12 score. Change', 'in SF-1: scores will be assessed utilizing a one-samplet-test. A two-sided 95% confidence interval will be', 'calculated based on the t-distribution.', 'Additionally, summary statistics (e.g. mean, SD, median, range) and graphical methods will be used to', 'summarize the change in SF-12 scores from baseline through 12 months.', 'Performance criteria', 'If the p-value from the one-sample t-test after adjusting for the Hommel procedure is < 0.025, the objective', 'will be considered met.', 'Determination of Subjects/Data for Analysis', 'All enrolled subjects who have the Arctic Front Advance Cardiac CryoAblation Catheter inserted into', 'vasculature and have completed baseline and 12 month questionnaires will be included.', '18.5. Ancillary Objectives', 'Ancillary objectives been defined to provide additional information about the performance of the Arctic Front', 'Advance Cardiac CryoAblation Catheter. No hypotheses are defined for regulatory or labeling purposes.', 'Version 4, 10NOV2016', 'Confidential']['056-F275, Clinical Investigation Plan Template, Version 2.0', 'Page 77 of 115', 'Version 4, 10NOV2016', 'Confidential']\n\n###\n\n", "completion": "END"}